Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study

Katarzyna Garbacz1, Lidia Piechowicz2, Aneta Mroczkowska3

  • 1Department of Oral Microbiology, Medical Faculty, Medical University of Gdansk, Gdansk, Poland.

Insights

Staphylococcus aureus respiratory infections in pediatric cystic fibrosis patients show diverse spa types, with macrolide resistance common in adolescents. Individualized colonization patterns suggest limited clonal spread, necessitating careful monitoring of antibiotic resistance.

Area of Science:

  • Microbiology
  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Staphylococcus aureus is a significant respiratory pathogen in children with cystic fibrosis (CF).
  • Understanding the diversity and relatedness of S. aureus strains is crucial for managing CF patients.
  • Assessing antimicrobial resistance patterns is essential for effective treatment strategies.

Purpose of the Study:

  • To determine the prevalence and relatedness of Staphylococcus aureus spa types in pediatric CF patients.
  • To analyze S. aureus isolates based on patient age groups.
  • To evaluate the antimicrobial resistance profiles of these isolates.

Main Methods:

  • Analysis of 165 S. aureus isolates from 82 pediatric CF patients over three years.
  • Molecular typing including spa typing and SCCmec typing.
  • Antimicrobial susceptibility testing was performed.

Main Results:

  • Sixty-four spa types were identified, including five novel types, with common clonal complexes (CC30, CC22, CC97, CC45, CC15).
  • Most patients (67.1%) harbored a single spa type, indicating individualized colonization.
  • High rates of macrolide (67.4%) and lincosamide (60.9%) resistance were observed, especially in adolescents (12-18 years).
  • Methicillin-resistant Staphylococcus aureus (MRSA) was found in 10.7% of patients, exclusively with monoclonal colonization.

Conclusions:

  • Staphylococcus aureus colonization in pediatric CF patients is highly diverse and predominantly individualized.
  • Limited evidence of clonal transmission suggests distinct infection dynamics.
  • High macrolide resistance, particularly in adolescents, warrants careful monitoring of macrolide therapy and periodic microbiological surveillance to prevent further resistance selection.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...